2.5.5 Disclosure of Significant Financial Interests and Management and Reporting of Financial Conflicts of Interest in Research

A. Purpose

This policy governs the disclosure of individual significant financial interests and the management and reporting of an individual financial conflict of interest in research performed at the University of Texas at Tyler (UT Tyler) and the University of Texas at Tyler Health Science Center (UTTHSC), including off-campus instructional sites (collectively the “University”).

This policy provides requirements for the disclosure of financial interests that comply with the disclosure requirements of federal regulations of the U.S. Department of Health and Human Services (HHS) and the HHS Public Health Service, but this policy is not limited in application to PHS funded research. Rather, this policy applies broadly to research performed at the University, without regard to whether the research has external funding and, if externally funded, regardless of the funding source. For this purpose, "research" means any systematic investigation, study, or experiment designed to develop or contribute to generalizable knowledge. The term includes both basic and applied research and product development.

This policy applies in addition to general institutional policies, such as policies on standards of conduct, as well as other policies governing disclosure of activities and financial interests.

If a specific federal law or regulation provides different requirements than this policy, the more stringent requirement applies.

B. Authority/Persons Affected

Any individual who, regardless of title or position, is responsible for the design, conduct, or reporting of research, including a principal investigator, co-investigator, or project director, must file and update financial disclosure statements under this policy. A person required to file and update financial disclosure statements is referred to in this policy as a “covered individual.”
A student enrolled at the institution who is responsible for the design, conduct, or reporting of research that is not PHS-funded is considered to be a "covered individual" under this policy only if the student has a significant financial interest that appears to be affected by the research or is in an entity whose financial interest appears to be affected by the research. A student who is in doubt about whether the student is a "covered individual" must request a determination by the Conflict of Interest Official.
Collaborators and Contractors
1. If research is carried out in cooperation with or through a subrecipient (e.g. a subcontractor, contractor, or collaborator), including a person identified under federal regulations as a "sub-recipient," the University must enter into a written agreement with the contracting party that provides legally enforceable terms that establish whether this policy or the financial conflicts of interest policy of the contracting party applies to the researchers of the contracting party.
2. If the policy of the contracting party applies to its researchers, the contracting party must certify that its policy is consistent with the requirements of any applicable federal regulations. If the contracting party cannot so certify, the agreement must state that the researchers are subject to this policy as covered individuals for disclosing significant financial interests that are directly related to the researcher’s work at the University.
3. If the policy of the contracting party applies to its researchers, the agreement must specify the time periods for the contracting party to report identified financial conflicts of interest to the University. The time periods must be sufficient for the University to make any reports required by federal regulation.
4. If the policy of the University applies to the researchers of the contracting party, the agreement must specify the time periods for the researchers to submit a financial interest disclosure statement to the University. The time periods must be sufficient for this institution to comply with its review, management, and reporting obligations under federal regulation.
Education
1. Each covered individual must acknowledge annually that the individual is aware of and has read this policy and is aware of the covered individual’s responsibilities regarding disclosure of significant financial interests and of applicable federal regulations.
2. A covered individual must complete training in regard to this policy and applicable policies, regulations, and laws before engaging in research at the University and at least once every four (4) years thereafter. A covered individual who is new to the University must complete the training before engaging in research at the University or provide evidence of having completed the training at another institution of The University of Texas System ("UT System") within the last four (4) years. A covered individual must complete the training immediately if the University finds that the individual is not in compliance with this policy or the individual’s management plan, or if the University revises this policy in a manner that affects the individual’s duties.
3. The Senior Vice President for Research and Dean of The Graduate School, or his/her designee, is responsible for ensuring that appropriate faculty, staff, trainees, and other persons participate in training in regard to this policy.

C. Definitions

PHS – Public Health Services
HHS – Human Health Services
Research - Any systematic investigation, study, or experiment designed to develop or contribute to generalizable knowledge. The term includes both basic and applied research and product development.
Covered Individual - A person required to file and update financial disclosure statements
Malign Foreign Talent Recruitment Program:
1. Compensation. Any program, position, or activity that includes compensation in the form of cash or in-kind compensation, which would include but is not limited to research funding; promised future compensation; complimentary foreign travel; things of non de minimis value; honorific title; career advancement opportunities; or other types of remuneration or consideration directly provided by a foreign country at any level (national, provincial, or local) or their designee or an entity based in, funded by, or affiliated with a foreign country, whether or not directly sponsored by the foreign country, to the targeted individual, whether directly or indirectly stated in the arrangement, contract, or other documentation at issue, in exchange for the individual:
  1. engaging in the unauthorized transfer of intellectual property, materials, data products, or other nonpublic information owned by a United States entity or developed with a Federal research and development award to the government of a foreign country or an entity based in, funded by, or affiliated with a foreign country, regardless of whether that government or entity provided support for the development of the intellectual property, materials, or data products;
  2. being required to recruit trainees or researchers to enroll in such program, position, or activity;
  3. establishing a laboratory or company, accepting a faculty position, or undertaking any other employment or appointment in a foreign country if such activities are in violation of the standard terms and conditions of a federal research and development award;
  4. being unable to terminate the foreign talent recruitment program contract or agreement except in extraordinary circumstances;
  5. through funding or effort related to the foreign talent recruitment program, being limited in the capacity to carry out a research and development award, or required to engage in work that would result in substantial overlap or duplication with a federal research and development award;
  6. being required to apply for and successfully receive funding from the sponsoring foreign government’s funding agencies with the sponsoring foreign organization as the recipient;
  7. being required to omit acknowledgment of the recipient organization with which the individual is affiliated or the federal research agency sponsoring the research and development award, contrary to the institutional policies or standard terms and conditions of the federal research and development award;
  8. being required to not disclose to the federal research agency or employing organization the participation of such individual in such program, position, or activity; or
  9. having a conflict of interest or conflict of commitment contrary to the standard terms and conditions of the federal research and development award.
Sponsors. A program that is sponsored by:
1. A foreign country of concern or an entity based in a foreign country of concern, whether or not directly sponsored by the foreign country of concern. Countries of concern include:
1. the People’s Republic of China
2. The Democratic People’s Republic of Korea
3. The Russian Federation
4. The Islamic Republic of Iran
5. Any other country deemed to be a country of concern by the U.S. Secretary of State;
b. An academic institution on the list developed under section 1286(c)(8) of the John S. McCain National Defense Authorization Act for Fiscal Year 2019; or

c. A foreign talent recruitment program on the list developed under section 1286(c)(9) of the John S. McCain National Defense Authorization Act for Fiscal Year 2019.

D. Policy and Procedure

Extent of Disclosure
1. As often as required by Section D.5, a covered individual shall complete or update a financial interest disclosure statement that:
  1. identifies all research in which the covered individual is engaged at the time of the disclosure; and
  2. discloses, as provided by Section D.2, each significant financial interest of the individual and covered family members that reasonably appears to be related to the individual’s institutional responsibilities.
  3. discloses any substantial relationship between themselves and any programs sponsored, funded, directed or controlled by a foreign government, foreign agency or foreign institution.
2. “Institutional responsibilities” means any of the professional responsibilities of a covered individual on behalf of the University, including research, research consultation, teaching, professional practice, institutional committee membership, or service on an institutional panel such as an Institutional Review Board (IRB) or Data and Safety Monitoring Board (DSMB).
3. In determining whether research or a financial interest should be disclosed, the covered individual should resolve the doubt in favor of disclosure.
Contents of Disclosure: Significant Financial Interests
1. The following interests are considered to be significant financial interests and, subject to the exclusions provided by Subsection (b) of this section, a covered individual’s disclosure statement must include the following information in regard to the covered individual and covered family members, but only in regard to interests that reasonably appear to be related to the individual’s institutional responsibilities:
  1. PAYMENTS RECEIVED FROM OR EQUITY INTEREST IN A PUBLICLY TRADED ENTITY: the total amount and source of payments received in the preceding twelve months from a publicly traded entity and the value of any equity interest held in the entity on the date of disclosure that, when aggregated, exceed $5,000, including:
    
    (1) as to payments received:
    
    (a) salary; and
    
    (b) any payment for services other than salary, such as consulting fees, honoraria, or paid authorship; and
    
    (2) as to equity interests held, any stock, stock options, or other ownership interest or entitlement to such an interest, valued by reference to public prices or other reasonable measures of fair market value;
  2. PAYMENTS RECEIVED FROM A NON-PUBLICLY TRADED ENTITY OR EQUITY INTEREST IN A NON-PUBLICLY TRADED ENTITY:
    
    (1) the total amount and source of payments received in the preceding twelve months from an entity that is not publicly traded that, when aggregated, exceed $5,000, including
    
    (a) salary; and
    
    (b) any payment for services other than salary, such as consulting fees, honoraria, or paid authorship; and
    
    (2) a description of any equity interest held in an entity that is not publicly traded, including any stock, stock options, or other ownership interests or entitlement to such an interest;
  3. INTELLECTUAL PROPERTY AND ROYALTIES:
    
    (1) a description of intellectual property rights held and any agreements to share in royalties related to those rights; and
    
    (2) the amount and source of royalty income that the covered individual or covered family member received or had the right to receive in the preceding twelve months;
  4. TRAVEL: reimbursed or sponsored travel in the preceding 12 months, including the purpose of the trip, the identity of the sponsor/organizer, the destination, the duration, and the value of the travel, if the aggregated value of all payments from the sponsor/organizer (such as salary, consulting fees, honoraria, or paid authorship and travel) exceeds $5000;
  5. GIFTS: the value and source of a single gift that the covered individual received in the preceding twelve months that exceeds $250 in value, or multiple gifts from a single entity that in the aggregate exceed $250 in value, other than gifts from a covered family member; and
  6. FIDUCIARY POSITIONS: a fiduciary position the covered individual held in a for- profit or nonprofit entity in the preceding twelve months, including a position as a member of the board of directors, an officer, or other executive or management position, for which the individual received any form of remuneration or reimbursement for expenses, and the name and principal address of the entity.
2. The following interests are not significant financial interests and need not be disclosed on the disclosure statement:
  1. salary, royalties, or other remuneration paid by the University to the covered individual, if the covered individual is currently employed or otherwise appointed by the University;
  2. income from seminars, lectures, or teaching engagements sponsored by a federal, state, or local government, an institution of higher education as defined by 20 U.S.C. 1001(a), an academic teaching hospital, a medical center, or a research institute affiliated with an institution of higher education;
  3. income from service on an advisory committee or review panel for a federal, state, or local government, an institution of higher education as defined by 20 U.S.C. 1001(a), an academic teaching hospital, a medical center, or a research institute affiliated with an institution of higher education;
  4. income from investment vehicles, such as mutual funds or retirement accounts, as long as the covered individual does not directly control the investment decisions made in those vehicles; or
  5. travel reimbursed or sponsored by a federal, state, or local government agency, an institution of higher education as defined by 20 U.S.C. 1001(a), an academic teaching hospital, a medical center, or a research institute that is affiliated with an institution of higher education.
3. In making disclosures under this section, the covered individual shall disclose the value of a significant financial interest within the following ranges:
  1. $0 - $4,999;
  2. $5,000 - $9,999;
  3. $10,000 - $19,999;
  4. amounts between $20,000 - $100,000 by increments of $20,000; or
  5. amounts above $100,000 by increments of $50,000.
4. When describing a source, the covered individual shall provide the name and principal address for the source. The covered individual shall distinguish among information pertaining to the covered individual and covered family members whose financial interests and activities are also disclosed by the covered individual.
5. The Conflict of Interest Official may request further information about a covered individual’s travel, including the monetary value of the travel, in order to determine whether the travel constitutes a financial conflict of interest.
Malign Foreign Talent Programs Prohibited. Employees are prohibited from participation in malign foreign talent programs.

4. Disclosure of Financial Interests of Other Persons: Covered Family Member
1. For purposes of disclosure under Section D.2, “covered family member” includes:
  1. a spouse;
  2. a dependent child or stepchild or other dependent, for purposes of determining federal income tax liability during the period covered by the disclosure statement; and
  3. a related or non-related, unmarried adult who resides in the same household as the covered individual and with whom the covered individual is financially interdependent as evidenced, for example, by the maintenance of a joint bank account, mortgage, or investments.
  4. any other person with whom the covered individual has joint financial interests such that an objective third party could reasonably conclude that the covered individual's decisions or other exercise of professional responsibilities at the institution could be influenced by the effect of that action on the person's financial interest.
2. If the covered individual is in doubt about whether an individual is a covered family member, the covered individual should resolve the doubt in favor of disclosure.
3. In disclosing financial interests, the interest of any legal entity, including a foundation or a trust that is controlled or directed by the individual or by the individual and covered family members, is considered to be the interest of the covered individual or covered family member as if the separate legal entity did not exist.
Text of Documentation to be Provided on Request

If a covered individual discloses payments, intellectual property interests, or royalties, the covered individual must provide a copy of any related agreement, contract, offer letter, or other documentation on request of:
1. the president of the University;
2. the Conflict of Interest Official; or
3. any other person or entity with administrative responsibility in regard to reviewing financial interest disclosure statements or approving a related management plan.
When to Disclose; Period Covered by Statement

A covered individual shall submit or update a financial interest disclosure statement:
1. not later than the 30th day of initial employment, covering the 12 months preceding the date of disclosure;
2. annually not later than March 1; and not later than the 30th day after acquiring a new financial interest that requires disclosure under Section D.2, such as receiving payments, an equity interest, intellectual property rights, or royalties that would require disclosure on an annual financial interest disclosure statement.
3. In addition, before a covered individual begins employment in any outside work or activity or receives from an outside source any compensation, or serves on any outside board, a description of the nature and extent of the employment or activity and the range of any compensation must be timely disclosed and approved by the President or his/her designee.
4. A covered individual who is planning to participate in a PHS-funded research project shall submit a financial interest disclosure statement not later than the time of application for PHS- funded research, except that an individual who is new to the University and who is planning to participate in an on-going PHS-funded research project shall submit the statement not later than the 30th day of initial employment.
5. The president of the institution or the Conflict of Interest Official may require a covered individual to submit additional disclosures.
Conflict of Interest Official. The Conflict of Interest Official for the University is the Chief Legal Officer. The Conflict of Interest Official shall perform the duties required by this policy and other duties as assigned by the President. Service as the Conflict of Interest Official is in addition to any other capacities in which the person serves the University.
Disclosure Statement Review; Determination of Financial Conflict of Interest
1. The Conflict of Interest Official shall review each financial interest disclosure statement and make two determinations:
  1. whether any significant financial interest disclosed is related to research in which the covered individual is engaged; and
  2. if so, whether a financial conflict of interest exists.
2. A significant financial interest is related to research in which the covered individual is engaged if the Conflict of Interest Official reasonably determines that the financial interest appears to be affected by the research or is in an entity whose financial interest appears to be affected by the research.
3. A financial conflict of interest exists when the Conflict of Interest Official reasonably determines that a significant financial interest could directly and significantly affect the design, conduct, or reporting of the research.
No Expenditure of Funds Prior to Review and Determination

Neither the University nor a covered individual may expend research funds unless the Conflict of Interest Official has determined that no financial conflict of interest exists or that any financial conflict of interest is manageable in accordance with the terms of a management plan that has been adopted and implemented in accordance with Sections D.10-12 of this policy.
Cooperation with Institutional Committees

The Conflict of Interest Official and the appropriate IRB, IACUC, IBC, and other relevant committees shall cooperate in the consideration of whether a covered individual has a financial conflict of interest in regard to human subjects research and in the development and implementation of a management plan for that conflict of interest.
Management Required for Financial Conflicts of Interest
1. If the Conflict of Interest Official determines that a covered individual has a financial conflict of interest, the Conflict of Interest Official, in cooperation with the covered individual and other appropriate individuals designated by the Conflict of Interest Official, shall develop a management plan governing that conflict of interest.
2. If research is ongoing and a new covered individual discloses a significant financial interest related to that research or any other covered individual discloses a new significant financial interest related to that research, the Conflict of Interest Official shall, not later than the 60th day after the filing of the disclosure statement:
  1. review the disclosure statement to determine if a financial conflict of interest exists; and
  2. if a financial conflict of interest exists, implement an interim management plan or implement other interim measures to ensure the objectivity of the research.
3. If the Conflict of Interest Official learns of a significant financial interest that was not timely disclosed or was not timely reviewed, the Conflict of Interest Official shall, not later than the 60th day after learning of the interest:
  1. determine whether the significant financial interest is a financial conflict of interest; and
  2. if a financial conflict of interest exists, implement an interim management plan or implement other interim measures to ensure the objectivity of the research going forward.
4. In addition, if a financial conflict of interest was not timely identified or managed, or if a covered individual fails to comply with a management plan, the Conflict of Interest Official shall, not later than the 120th day after determining noncompliance:
  1. complete and document a retrospective review and determination as to whether research conducted during the period of noncompliance was biased in the design, conduct, or reporting of the research; and
  2. implement any measures necessary with regard to the covered individual’s participation in the research between the date that the noncompliance is identified and the date the retrospective review is completed.
5. For PHS-covered research projects, the retrospective review shall cover key elements as specified by federal regulations and may result in updating the Financial Conflict of Interest Report described by Section 15.b, notifying the PHS, and submitting a mitigation report as required by federal regulation.
Management Plan Design and Agreement
1. A management plan may impose conditions and prescribe actions necessary to manage a financial conflict of interest, including an action reducing or eliminating the financial conflict of interest, to ensure that the design, conduct, or reporting of the research is free from bias or the appearance of bias. Examples of conditions or actions that may be prescribed include:
  1. public disclosure of the conflict of interest in presentations and publications;
  2. for human subjects research, direct disclosure of the conflict of interest to research participants;
  3. appointment of an independent monitor with authority to take measures to protect the design, conduct, and reporting of research against bias, or the appearance of bias, resulting from the conflict of interest;
  4. modification of the research plan;
  5. change of personnel or personnel responsibilities, or disqualification of personnel from participation in all or a portion of the research;
  6. divesture or reduction of the financial interest; or
  7. severance of relationships that create an actual or potential financial conflict of interest.
2. A management plan must be in the form of a written agreement and must:
  1. provide that the covered individual acknowledges receipt of the plan and understands the requirements of this policy and understands and agrees to comply with the required actions and other terms of the plan, including the time frames for required actions; and
  2. clearly identify each specific person responsible for monitoring compliance with the management plan.
Monitoring and Compliance

Each person conducting research under a management plan shall comply fully and promptly with the plan, and each person identified in the management plan as having responsibility for monitoring compliance with the plan shall carefully and fully monitor that compliance.
Web Posting of Financial Conflict of Interest Information

Posting of this Policy. This policy and each update of this policy must be publicly accessible through the Internet.
Posting of Information Regarding Specific Financial Conflicts of Interest
1. For each financial conflict of interest that is found to exist by the Conflict of Interest Official, the University will make the following information available to the public through the Internet in regard to each covered individual who contributes to the scientific development or execution of the research project in a substantive, measurable way, including a covered individual who is the project director or principal investigator:
  1. the covered individual’s name;
  2. the covered individual’s title and role with respect to the research;
  3. the name of the entity in which the significant financial interest is held;
  4. the nature of the significant financial interest that constitutes a financial conflict of interest; and
  5. the approximate value of the significant financial interest by range or, if the dollar value cannot be determined by reference to public prices or other reasonable measures of fair market value, a statement to that effect.
2. The approximate dollar value of the significant financial interest shall be provided within the following ranges if it can determined by reference to public prices or other reasonable measures of fair market value:
  1. $0 - $4,999;
  2. $5,000 - $9,999;
  3. $10,000 - $19,999;
  4. amounts between $20,000 - $100,000 by increments of $20,000; or
  5. amounts above $100,000 by increments of $50,000.
3. The University will update the information required by this section annually. In addition, for any financial conflict of interest of a covered individual whose information must be posted under this section and for which the information was not previously posted, the University will make the information required by this section available not later than the 60th day after the financial conflict of interest is identified.
4. The website on which the information is posted must note that the information is current as of the date listed and is subject to updates.
5. The information required by this section must remain available on the Internet for three (3) years after its most recent update.
6. For PHS-funded research, in regard to project directors, principal investigators, and other senior or key personnel, this information must be available through the Internet before expending PHS funds.
Certification and Reports to PHS
1. Certification and Report Required
  
  Federal regulations require that each application for funding to the PHS include specific certifications and agreements in regard to this policy and financial conflicts of interest. Federal regulations also require that the University make the reports required by this policy for PHS- funded research.
2. Financial Conflict of Interest Report
  
  Before the expenditure of any funds under a PHS-funded research project, the appropriate institutional officials will make the Financial Conflict of Interest Report to the PHS awarding component in compliance with 42 CFR Part 50, Subpart F, and 45 CFR Part 94. In general, those regulations require a Financial Conflict of Interest Report regarding those interests that the University determines are financial conflicts of interest, including financial conflicts of interest of sub-recipients. The reporting will include specified information sufficient to enable the awarding component to understand the nature and extent of the financial conflict and to assess the appropriateness of the management plan related to the conflict of interest. The federal regulations require reporting within a specified period of financial conflicts of interest identified subsequent to an earlier report and require annual updating of reports regarding previously disclosed financial conflicts of interest. This will be handled by the Director of Office of Sponsored Programs who will be responsible for reporting of financial conflicts of interest.
Disclosure is a Condition of Employment or Relationship to Institution
1. Timely, complete, and accurate disclosure of activities and financial interests consistent with this policy is a condition of employment at the University, and a covered individual who does not comply with this policy is subject to discipline, including termination of employment.
2. For a covered individual who is not an employee of the University, compliance with this policy is a condition of participating with the institution in the capacity that qualifies the person as a covered individual. The University may require the individual to execute a document certifying that the individual knows that compliance with this policy is a condition of participation.
Federal Enforcement
1. Federal regulations, 42 CFR Part 50, Subpart F, and 45 CFR Part 94, require the University to notify the PHS of instances in which the failure of a covered individual to comply with this policy or a management plan appears to have biased the design, conduct, or reporting of PHS- funded research. The PHS awarding component may take enforcement action or require the University to take action appropriate to maintaining objectivity in the research. The University must make information available to HHS or the PHS awarding component as required by federal regulation.
2. If the HHS determines clinical research funded by PHS to evaluate the safety or effectiveness of a drug, medical device, or treatment has been designed, conducted, or reported by a covered individual with a financial conflict of interest that was not managed or reported by the University as required by federal regulation, the University will require the covered individual involved to disclose the financial conflict of interest in each public presentation of the results of the research and to request an addendum to previously published presentations.
Oversight and Authority

The Senior Vice President for Research and Dean of The Graduate School is responsible for overseeing implementation of this policy and who may provide additional procedures and supplementary forms, as appropriate, consistent with this policy and applicable sponsor regulations.
Records
1. Records regarding the disclosure of financial interests and the management of a conflict of interest, including financial interest disclosure statements, a reviewing official's determinations, and other records of institutional actions, shall be retained for the longer of at least three (3) years after:
  1. the date of creation;
  2. the date of termination or completion of a research award or contract, or the submission of the final expenditures report, for research identified in a disclosure statement; or
  3. the date of final resolution of any investigation, audit, or similar action involving the records.
2. The University will provide for a centralized repository for financial interest disclosure statements, management plans, and related records.
3. The Conflict of Interest Official, or another person designated by the President, shall provide the Chancellor of The University of Texas System with copies of all guidelines, procedures, and forms used by the University relating to financial conflicts of interest and shall ensure that the Chancellor receives copies of any revised guidelines, procedures, and forms simultaneously with the implementation of the revision. The University will provide data reported in accordance with UTS 175 to UT System Administration upon request.
Audits

The University will provide for regular audits of financial interest disclosure statements to determine individual and institutional compliance with this policy.

E. References

Board of Regent's Rule 30104, Conflict of Interest, Conflict of Commitment, and Outside Activities Board of Regent's Rule 90000 Series, Intellectual Property

UTS 180, Conflicts of Interest, Conflicts of Commitment, and Outside Activities

UTS 175, Disclosure of Significant Financial Interests and Management and Reporting of Financial Conflicts of Interest in Research

42 CFR Part 50

45 CFR Part 94

National Science Foundation Grant Policy Manual Section 510

Texas Education Code, Section 51.912, Equity Ownership; Business Participation

Texas Government Code, Chapter 572, Personal Financial Disclosure, Standards of Conduct, and Conflict of Interest

Originally Approved: 11/02/2012

Reviewed: AY 1819

Amended: 01/2022

Up one level

Series 200 General Policies and Procedures